Baidu
map
NUCLEOS NUCLEOT NUCL 润色咨询

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

出版年份：2000 年文章数：1373 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：21.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2240329, encodeId=05762240329f7, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿，18天被拒，推荐投旗下其他期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2639534401, createdName=ms3000000868814273, createdTime=Mon Dec 02 01:26:29 CST 2024, time=2024-12-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2136025, encodeId=2a32213602522, content=投稿一年多，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220117/a0d5bf74b20344f6a87ed53c6c6d0a9d/b5c8538f572141cebaaa5ca0336fbf84.jpg, createdBy=13e05495903, createdName=ms2000001025929906, createdTime=Tue May 16 23:42:23 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095752, encodeId=ca171095e52eb, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095751, encodeId=c77e1095e519c, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542960, encodeId=80615429604b, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496368, encodeId=33db49636815, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：关于药物作用于细胞的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 18 10:45:00 CST 2013, time=2013-06-18, status=1, ipAttribution=)]
    2024-12-02 ms3000000868814273 来自湖南省

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：投稿，18天被拒，推荐投旗下其他期刊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2240329, encodeId=05762240329f7, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿，18天被拒，推荐投旗下其他期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2639534401, createdName=ms3000000868814273, createdTime=Mon Dec 02 01:26:29 CST 2024, time=2024-12-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2136025, encodeId=2a32213602522, content=投稿一年多，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220117/a0d5bf74b20344f6a87ed53c6c6d0a9d/b5c8538f572141cebaaa5ca0336fbf84.jpg, createdBy=13e05495903, createdName=ms2000001025929906, createdTime=Tue May 16 23:42:23 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095752, encodeId=ca171095e52eb, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095751, encodeId=c77e1095e519c, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542960, encodeId=80615429604b, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496368, encodeId=33db49636815, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：关于药物作用于细胞的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 18 10:45:00 CST 2013, time=2013-06-18, status=1, ipAttribution=)]
    2023-05-16 ms2000001025929906 来自四川省

    投稿一年多，还在with editor

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2240329, encodeId=05762240329f7, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿，18天被拒，推荐投旗下其他期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2639534401, createdName=ms3000000868814273, createdTime=Mon Dec 02 01:26:29 CST 2024, time=2024-12-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2136025, encodeId=2a32213602522, content=投稿一年多，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220117/a0d5bf74b20344f6a87ed53c6c6d0a9d/b5c8538f572141cebaaa5ca0336fbf84.jpg, createdBy=13e05495903, createdName=ms2000001025929906, createdTime=Tue May 16 23:42:23 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095752, encodeId=ca171095e52eb, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095751, encodeId=c77e1095e519c, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542960, encodeId=80615429604b, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496368, encodeId=33db49636815, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：关于药物作用于细胞的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 18 10:45:00 CST 2013, time=2013-06-18, status=1, ipAttribution=)]
    2021-12-29 rayms

    如何计算相关性？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2240329, encodeId=05762240329f7, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿，18天被拒，推荐投旗下其他期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2639534401, createdName=ms3000000868814273, createdTime=Mon Dec 02 01:26:29 CST 2024, time=2024-12-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2136025, encodeId=2a32213602522, content=投稿一年多，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220117/a0d5bf74b20344f6a87ed53c6c6d0a9d/b5c8538f572141cebaaa5ca0336fbf84.jpg, createdBy=13e05495903, createdName=ms2000001025929906, createdTime=Tue May 16 23:42:23 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095752, encodeId=ca171095e52eb, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095751, encodeId=c77e1095e519c, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542960, encodeId=80615429604b, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496368, encodeId=33db49636815, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：关于药物作用于细胞的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 18 10:45:00 CST 2013, time=2013-06-18, status=1, ipAttribution=)]
    2021-12-27 MS54455111222

    p<0.05够么？什么时候要求p<0.01?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2240329, encodeId=05762240329f7, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿，18天被拒，推荐投旗下其他期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2639534401, createdName=ms3000000868814273, createdTime=Mon Dec 02 01:26:29 CST 2024, time=2024-12-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2136025, encodeId=2a32213602522, content=投稿一年多，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220117/a0d5bf74b20344f6a87ed53c6c6d0a9d/b5c8538f572141cebaaa5ca0336fbf84.jpg, createdBy=13e05495903, createdName=ms2000001025929906, createdTime=Tue May 16 23:42:23 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095752, encodeId=ca171095e52eb, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095751, encodeId=c77e1095e519c, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542960, encodeId=80615429604b, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496368, encodeId=33db49636815, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：关于药物作用于细胞的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 18 10:45:00 CST 2013, time=2013-06-18, status=1, ipAttribution=)]
    2017-07-14 weiwei_zhu

    反正就这个熊样,也不会有所变化,只要不跌,也就万幸了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2240329, encodeId=05762240329f7, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿，18天被拒，推荐投旗下其他期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2639534401, createdName=ms3000000868814273, createdTime=Mon Dec 02 01:26:29 CST 2024, time=2024-12-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2136025, encodeId=2a32213602522, content=投稿一年多，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220117/a0d5bf74b20344f6a87ed53c6c6d0a9d/b5c8538f572141cebaaa5ca0336fbf84.jpg, createdBy=13e05495903, createdName=ms2000001025929906, createdTime=Tue May 16 23:42:23 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095752, encodeId=ca171095e52eb, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095751, encodeId=c77e1095e519c, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542960, encodeId=80615429604b, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496368, encodeId=33db49636815, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：关于药物作用于细胞的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jun 18 10:45:00 CST 2013, time=2013-06-18, status=1, ipAttribution=)]
    2013-06-18 匿名用户

    审稿速度:6.0 | 投稿命中率:75.0
    经验分享：关于药物作用于细胞的杂志

    0

共10条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map